GB201314577D0 - Intracellular immunity - Google Patents

Intracellular immunity

Info

Publication number
GB201314577D0
GB201314577D0 GB201314577A GB201314577A GB201314577D0 GB 201314577 D0 GB201314577 D0 GB 201314577D0 GB 201314577 A GB201314577 A GB 201314577A GB 201314577 A GB201314577 A GB 201314577A GB 201314577 D0 GB201314577 D0 GB 201314577D0
Authority
GB
United Kingdom
Prior art keywords
intracellular immunity
immunity
intracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201314577A
Other versions
GB2517190A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB1314577.6A priority Critical patent/GB2517190A/en
Publication of GB201314577D0 publication Critical patent/GB201314577D0/en
Publication of GB2517190A publication Critical patent/GB2517190A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6839Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting material from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
GB1314577.6A 2013-08-14 2013-08-14 Intracellular immunity Withdrawn GB2517190A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1314577.6A GB2517190A (en) 2013-08-14 2013-08-14 Intracellular immunity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1314577.6A GB2517190A (en) 2013-08-14 2013-08-14 Intracellular immunity

Publications (2)

Publication Number Publication Date
GB201314577D0 true GB201314577D0 (en) 2013-09-25
GB2517190A GB2517190A (en) 2015-02-18

Family

ID=49262177

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1314577.6A Withdrawn GB2517190A (en) 2013-08-14 2013-08-14 Intracellular immunity

Country Status (1)

Country Link
GB (1) GB2517190A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521291A (en) * 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
US20100266620A1 (en) * 2006-01-20 2010-10-21 Le Sun Immunoconjugates for treatment of infectious diseases
GB201202268D0 (en) * 2012-02-09 2012-03-28 Medical Res Council Intracellular immunity

Also Published As

Publication number Publication date
GB2517190A (en) 2015-02-18

Similar Documents

Publication Publication Date Title
HK1222846A1 (en) Substituted benzylpyrazoles
HK1221717A1 (en) Substituted benzylpyrazoles
GB201413149D0 (en) No details
HRP20171890T1 (en) Substituted imidazopyridazines
GB201410903D0 (en) No details
HK1223362A1 (en) Substituted pyrazolo-pyridinamines
GB201418212D0 (en) No details
GB201418129D0 (en) No details
PL3068827T3 (en) Bitumenpolymerzusammensetzung mit verbesserten mechanischen kälteeigenschaften
GB201421548D0 (en) No details
HK1220972A1 (en) Substituted thiazolopyrimidines
IL246271A0 (en) Substituted piperidinyl-tetrahydroquinolines
GB201408089D0 (en) No details
GB201418214D0 (en) No details
GB201416327D0 (en) No details
GB201407200D0 (en) No details
EP2975313A4 (en) Fluid-throttling member
GB201417843D0 (en) No details
PL2846091T3 (en) Oxy-gas-brenner mit glühzündung
GB201321332D0 (en) Fitting
GB201202268D0 (en) Intracellular immunity
GB201314577D0 (en) Intracellular immunity
GB201420267D0 (en) No details
GB201420520D0 (en) No details
GB201216568D0 (en) Intracellular immunity

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)